期刊文献+

240例胃神经内分泌肿瘤的临床病理特征及预后分析 被引量:13

Clinicopathologic features and prognostic analysis of 240 patients with gastric neuroendocrine neoplasms
原文传递
导出
摘要 目的探讨胃神经内分泌肿瘤(G⁃NEN)的临床病理特征并分析影响预后的因素。方法采用回顾性病例对照研究方法,分析2000年1月至2018年6月期间在解放军总医院经病理检查并确诊为G⁃NEN患者的临床病理资料,排除合并脏器病变、其他脏器原发性肿瘤、精神疾病及临床病理资料不完整者后,共纳入240例患者的病例资料。采用“胃癌专病数据库系统”进行临床及随访数据资料采集。汇总患者体格检查信息、肿瘤特征和病理特征,并采用Cox回归模型分析影响G⁃NEN患者预后的危险因素。采用Kaplan⁃Meier法绘制生存曲线,并用log⁃rank检验分析组间生存率的差异。结果240例G⁃NEN患者年龄(60.3±10.1)岁,男性181例(75.4%),女性59例(24.6%)。肿瘤直径(4.2±2.8)cm,神经内分泌瘤(NET)51例(21.2%),神经内分泌癌(NEC)139例(57.9%),混合性腺神经内分泌癌(MANEC)50例(20.8%);G1低级别28例(11.7%),G2中级别34例(14.2%),G3高级别178例(74.2%);肿瘤浸润深度T1~4分别为44例(18.3%)、27例(11.2%)、60例(25.0%)和109例(45.4%);163例(67.9%)发生淋巴结转移,46例(19.2%)发生远处转移;Ⅰ~Ⅳ期患者分别为55例(22.9%)、42例(17.5%)、94例(39.2%)和53例(22.1%)。240例G⁃NEN患者中,223例(92.9%)获得随访,中位生存时间为39.2(95%CI:29.1~47.5)个月。单因素分析结果显示,年龄≥60岁、肿瘤直径≥4.2 cm、肿瘤分级为G3、淋巴结转移、远处转移、肿瘤分期(Ⅲ~Ⅳ)均是影响G⁃NEN患者预后的危险因素(均P<0.05);多因素分析结果显示,淋巴结转移(HR=1.783,95%CI:1.007~3.155,P=0.047)和远处转移(HR=2.288,95%CI:1.307~4.008,P=0.004)是影响G⁃NEN患者生存的独立危险因素。进一步亚组分析本组G3高级别G⁃NEN显示,NET⁃G3的5年生存率为76.19%,高于NEC⁃G3和MANEC⁃G3(分别为15.60%和24.73%,P=0.012),差异有统计学意义。结论G⁃NEN患者在诊断时,多已处于进展期,存在淋巴结转移和远处转移提示患者预后较差。高增殖NET⁃G3患者的预后好于NEC⁃G3及MANEC⁃G3,是一类值得进一步关注的分类。 Objective To investigate clinicopathological features and prognostic factors of gastric neuroendocrine tumors(G⁃NEN).Methods Clinical and pathological data of patients with G⁃NEN diagnosed by pathological examination in Chinese PLA General Hospital from January 2000 to June 2018 were retrospectively analyzed in this case⁃control study.Patients with complicated visceral lesions,other visceral primary tumors,mental disorders and incomplete clinicopathological data were excluded.Finally,240 hospitalized patients who met the inclusion criteria were enrolled.Physical examination information,tumor characteristics and pathological characteristics of patients were summarized.The Cox regression models were used to analyze the risk factors affecting G⁃NEN and the survival conditions were described by Kaplan⁃Meier survival curves and log⁃rank test.Results In 240 patients with G⁃NEN,the mean age was(60.3±10.1)years;181 were male(75.4%)and 59 females(24.6%);mean tumor diameter was(4.2±2.8)cm;51 cases(21.2%)were neuroendocrine tumor(NET),139 cases(57.9%)neuroendocrine carcinoma(NEC),50 cases(20.8%)mixed neuroendocrine carcinoma(MANEC);28 cases(11.7%)were G1 low grades,34 cases(14.2%)G2 medium grades,and 178 cases(74.2%)G3 high grades;tumor infiltration depth T1 to T4 were 44 cases(18.3%),27 cases(11.2%),60 cases(25.0%)and 109 cases(45.4%)respectively;163 cases(67.9%)developed lymphatic metastasis and 46 patients(19.2%)distant metastasis;tumor stage from stage I to stage IV were 55 cases(22.9%),42 cases(17.5%),94 cases(39.2%)and 53 cases(22.1%)respectively.Of the 240 G⁃NEN patients,223 cases(92.9%)were followed up.The median survival time of the patients was 39.2(95%CI:29.1 to 47.5)months.Univariate survival analysis showed that age≥60 years,tumor diameter≥4.2 cm,tumor grade G3,lymphatic metastasis,distant metastasis,and tumor stage III⁃IV were risk factors for G⁃NEN patients.Multivariate survival analysis revealed that lymphatic metastasis(HR=1.783,95%CI:1.007⁃3.155,P=0.047)and distant metastasis(HR=2.288,95%CI:1.307⁃4.008,P=0.004)were independent risk factors of the prognosis.Further analysis of the G3 subgroup of G⁃NEN showed that the 5⁃year survival rate of NET⁃G3 was 76.19%,which was significantly higher than that of NEC⁃G3 and MANEC⁃G3(15.60%and 24.73%,P=0.012).Conclusions Most G⁃NEN patients are in advanced stage at diagnosis.Lymphatic metastasis and distant metastasis indicate poor prognosis.The prognosis of high proliferation NET⁃G3 patients is better as compared to those of NEC⁃G3 and MANEC⁃G3.This classification is worth further attention.
作者 梁文全 张旺 乔屾 王保华 王闯 庄紫伟 郗洪庆 蔡爱珍 卫勃 陈凛 Liang Wenquan;Zhang Wang;Qiao Shen;Wang Baohua;Wang Chuang;Zhuang Ziwei;Xi Hongqing;Cai Aizhen;Wei Bo;Chen Lin(Department of General Surgery&Institute of General Surgery,First Medical Center of Chinese PLA General Hospital,Beijing 100853,China;Medical Big Data Center&National Engineering Laboratory,Chinese PLA General Hospital,Beijing 100853,China)
出处 《中华胃肠外科杂志》 CAS CSCD 北大核心 2020年第1期38-43,共6页 Chinese Journal of Gastrointestinal Surgery
基金 国家自然科学基金(8167100011) 解放军总医院医疗大数据研发项目(2016MBD⁃012)。
关键词 神经内分泌肿瘤 临床病理特征 预后 Neuroendocrine neoplasms gastric Clinicopathologic features Prognosis
  • 相关文献

参考文献10

二级参考文献46

  • 1Simona Grozinsky-Glasberg,Dimitrios Thomas,Jonathan R Strosberg,Ulrich-Frank Pape,Stephan Felder,Apostolos V Tsolakis,Krystallenia I Alexandraki,Merav Fraenkel,Leonard Saiegh,Petachia Reissman,Gregory Kaltsas,David J Gross.Metastatic type 1 gastric carcinoid:A real threat or just a myth?[J].World Journal of Gastroenterology,2013,19(46):8687-8695. 被引量:12
  • 2Yong Hwan Kwon,Seong Woo Jeon,Gwang Ha Kim,Jin Il Kim,Il-Kwun Chung,Sam Ryong Jee,Heung Up Kim,Geom Seog Seo,Gwang Ho Baik,Kee Don Choi,Jeong Seop Moon.Long-term follow up of endoscopic resection for type 3 gastric NET[J].World Journal of Gastroenterology,2013,19(46):8703-8708. 被引量:16
  • 3Martin Anlauf,Nele Garbrecht,Tobias Henopp,Anja Schmitt,Regina Schlenger,Andreas Raffel,Markus Krausch,Oliver Gimm,Claus F Eisenberger,Wolfram T Knoefel,Henning Dralle,Paul Komminoth,Philipp U Heitz,Aurel Perren,Günter Klppel.Sporadic versus hereditary gastrinomas of the duodenum and pancreas: Distinct clinico-pathological and epidemiological features[J].World Journal of Gastroenterology,2006,12(34):5440-5446. 被引量:7
  • 4岳欣,顾锋,夏维波,萧新华,李梅,邢小平,曾正陪,向红丁,连小兰,伍学焱.胰岛素瘤的术前定性及定位诊断99例分析[J].中国实用内科杂志:临床前沿版,2006,26(11):1795-1797. 被引量:16
  • 5Yao JC, Hassan M ,Phan A,et al. One hundred years after"carci- noid" : epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States [J].J Clin Oncol, 2008,26(18): 3063-3072.
  • 6Leotlela PD,Jauch A,Hohgrew-Grez H,et al. Genetics of neu- roendocrine and carcinoid tumours [J].Endocr Relat Cancer, 2003,10(4) : 437-450.
  • 7Ramage JK, Davies AH, Ardill J, et al. Guidelines for the man- agement of gastroenteropanereatie neuroendoerine (including carcinoid) tumours[Jl.Gut,2005, 54 (suppl 4): 1-16.
  • 8Modlin IM, Moss SF, Chung DC, et al. Priorities for improving the management of gastroenteropancreatic neuroendocrine tumors [ J ].J Natl Cancer Inst, 2008,100(18): 1282-1289.
  • 9Kloppel G, Couvelard A, Perren A, et al. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors : towards a standardized approach to the diagnosis of gastroentero- pancreatic neuroendocrine tumors and their prognostic stratifica-tion [J].Neuroendocrinology, 2009,90(2): 162-166.
  • 10Rarnage JK, Ahmed A, Ardill J, et al. Guidelines for the manage- ment of gastroenteropanereatic neuroendocrine (including carci- noid) tunrnurs (NETs) [ J ].Gut, 2012,61 ( 1 ) : 6-32.

共引文献293

同被引文献116

引证文献13

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部